Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin

BACKGROUND: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a newly discovered oncogene. It is an active cell proliferation regulatory factor that inhibits tumor apoptosis in gastric cancer (GC) cells. CIP2A is functionally related to chemoresistance in various types of tumors according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yong-Xun, Ma, Li-Bin, Yang, Ze, Wang, Fang, Wang, Hui-Ying, Dang, Jia-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994047/
https://www.ncbi.nlm.nih.gov/pubmed/36908323
http://dx.doi.org/10.4251/wjgo.v15.i2.286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994047/
https://www.ncbi.nlm.nih.gov/pubmed/36908323
http://dx.doi.org/10.4251/wjgo.v15.i2.286

Ejemplares similares